Induction therapy for locally advanced esophageal or gastric cancer: A phase I/II trial of paclitaxel, carboplatinum, 5-FU and radiation therapy followed by surgery.

被引：0
|
作者：
Whiton, MA [1 ]
Anne, PR [1 ]
Curran, WJ [1 ]
机构：
[1] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2003年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
235
引用
收藏
页码：S131 / S132
页数：2
相关论文
共 50 条
  • [1] Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer
    Roof, Kevin S.
    Coen, John
    Lynch, Thomas J.
    Wright, Cameron
    Fidias, Panos
    Willett, Christopher G.
    Choi, Noah C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04): : 1120 - 1128
  • [2] Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    McClurkan, S
    Gray, JR
    Stroup, SL
    Burris, HA
    Yardley, DA
    Bradof, JE
    Yost, K
    Ellis, JK
    Greco, FA
    [J]. CANCER JOURNAL, 2002, 8 (04): : 311 - 321
  • [3] Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer
    Pera, M.
    Gallego, R.
    Montagut, C.
    Martin-Richard, M.
    Iglesias, M.
    Conill, C.
    Reig, A.
    Balague, C.
    Petriz, L.
    Momblan, D.
    Bellmunt, J.
    Maurel, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (03) : 664 - +
  • [4] Neoadjuvant Therapy in locally advanced Oral cancer: Chemotherapy induction with Docetaxel/Cisplatin/5-FU followed by concurrent radiation therapy plus Docetaxel/Cisplatin followed by Surgery - Phase I Study: Results and 3J-FU
    Grehl, S.
    Eberhardt, W.
    Poettgen, C.
    Abu Jawad, J.
    Kaelberlah, H. -P
    Gauler, T.
    Arnold, G.
    Mohr, C.
    Stuschke, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 90 - 90
  • [5] A phase II trial of preoperative paclitaxel, carboplatin, 5-FU and radiation in patients with resectable esophageal or gastric cancer (Ca)
    Anne, PR
    Axelrod, R
    Rosato, E
    Rosato, F
    Kairys, J
    Ramirez, M
    Cantor, R
    Chapman, A
    Curran, W
    Mitchell, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 321S - 321S
  • [6] Neo-adjuvant radiation, cisplatin, 5-FU +/- paclitaxel in locally advanced esophageal cancer.
    Roof, KS
    Coen, J
    Lynch, TJ
    Wright, CD
    Fidias, P
    Willett, CG
    Choi, NC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 324S - 324S
  • [7] Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer.
    Enzinger, P. C.
    Yock, T.
    Suh, W.
    Fidias, P.
    Mamon, H.
    Choi, N.
    Lehman, N.
    Lawrence, C.
    Lynch, T.
    Fuchs, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 194S - 194S
  • [8] Palliative Radiation Therapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial
    Tey, J.
    Lee, K. M.
    Leong, C. N.
    Zheng, H.
    Koh, W. Y.
    Lim, K. H. C.
    Soon, Y. Y.
    Tham, I.
    Lu, J. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E134 - E135
  • [9] Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: Final results of a minnie pearl cancer research network phase II trial
    Meluch, AA
    Greco, FA
    Gray, JR
    Thomas, M
    Sutton, VM
    Davis, JL
    Kalman, LA
    Shaffer, DW
    Yost, K
    Rinaldi, DA
    Hainsworth, JD
    [J]. CANCER JOURNAL, 2003, 9 (04): : 251 - 260
  • [10] Concomitant 5-FU, hydroxyurea and cisplatin with external beam radiation therapy for locally advanced pancreatic cancer: A phase II study
    Chen, LM
    Haraf, D
    Brachman, DG
    Vokes, EE
    Schilsky, RL
    [J]. ONCOLOGY REPORTS, 1997, 4 (05) : 877 - 881
12345